Novo Nordisk A/S (NYSE:NVO) Stock Position Cut by Cambridge Investment Research Advisors Inc.
Cambridge Investment Research Advisors Inc. lessened its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 14.4% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 160,726 shares of the company’s stock after selling 26,945 shares during the period. Cambridge Investment Research Advisors […]
